It has been reported recently that Haemophilus influenzae (P ⍧ 0.009). Western blot analysis confirmed that the H. influenzae-positive patients' IgG recognized the can elicit an axonal form of Guillain-Barré syndrome. 
Introduction
Guillain-Barré syndrome, an acute inflammatory, recently identified as the most common cause of preceding infection in Guillain-Barré syndrome (Kaldor and Speed, predominantly motor polyneuropathy (Asbury and Cornblath, 1990) , is preceded by an acute infectious illness in 1984; Winer et al., 1988; Mishu and Blaser, 1993; Rees et al., 1995b) , and C. jejuni-related Guillain-Barré syndrome approximately two-thirds of cases, the onset of neuropathic symptoms being preceded by respiratory infection in 30-is speculated to be associated with axonal degeneration of the motor nerves (Yuki et al., 1990; Rees et al., 1995a ; 45% of cases and by gastrointestinal infection in 15-20% of cases (Winer et al., 1988; Boucquey et al., 1991) . Various Visser et al., 1995) or positivity for anti-ganglioside GM1 antibody (Rees et al., 1995a; Jacobs et al., 1996) . Molecular infectious agents are reported as possibly having an association with Guillain-Barré syndrome (Winer et al., mimicry between the GM1 in neural tissue and the GM1-like structure on the lipopolysaccharide (LPS) of C. jejuni 1988; Ropper et al., 1991) , but the causal relationship between the infectious agent for prodromal illness and peripheral has also been suggested (Yuki et al., 1992a Oomes et al., 1995) . The majority of Guillain-Barré syndrome nerve damage is not known. Campylobacter jejuni was patients, however, have had prodromal respiratory infection.
blocked with 200 µl solution B (20 mmol/l Tris buffer, pH 7.4, 100 mmol/l NaCl, 3% skim milk, 0.05% Tween-20) Cytomegalovirus (CMV), Epstein-Barr virus (EBV) and Mycoplasma pneumoniae are also possible causes of overnight. The plates were then incubated overnight with 100 µl serum diluted 1 : 1000 in solution B, after which they respiratory tract infections that precede Guillain-Barré syndrome, but their frequencies are Ͻ15% (Winer et al., were washed and incubated for 90 min at room temperature with peroxidase-conjugated goat anti-human IgG, IgM and 1988; Boucquey et al., 1991; Hao et al., 1998; Jacobs et al., 1998) .
IgA diluted 1 : 2000 in solution A. After another wash, the plates were developed with the substrate solution [containing We reported recently a patient with Guillain-Barré syndrome subsequent to respiratory infection by Haemophilus 2,2Ј-azino-bis-(3-ethylbenzothiazoline sulphonate) (ABTS; Zymed, San Francisco, Calif., USA) and hydrogen peroxide influenzae and the possible presence of a GM1-like structure on the surface of this bacterium (Mori et al., 1999) 
Subjects
influenzae-positive if they had elevated anti-H. influenzae Forty-six consecutive Guillain-Barré syndrome patients seen antibody for two or three classes of IgG, IgM or IgA. at Chiba University Hospital or its affiliated hospitals between January 1989 and June 1998 were studied. All fulfilled the clinical criteria for Guillain-Barré syndrome (Asbury and Cornblath, 1990) . Clinical disabilities were evaluated by
Western blot analysis
Hughes functional grading (Hughes et al., 1978) , and patients Purified H. influenzae LPS (Westphal et al., 1965) was were followed for up to 3 months after onset. Serum prepared as described previously, from the non-typable strain samples obtained within 4 weeks of the onset of neurological used in the ELISA described above. Escherichia coli LPS was symptoms were stored at -80°C until used. Whenever purchased from Difco Laboratories (Mich., USA). Sodium possible, sputum or stool samples were collected from each dodecyl sulphate-polyacrylamide gel electrophoresis was patient. Serum samples from 49 normal controls and 51 performed according to Laemmli (Laemmli, 1970) ; the patients with other neurological diseases seen during the separating gels contained 15% acrylamide and 2 M urea. All same period, including 24 patients with multiple sclerosis the preparations were transferred electrophoretically onto and 27 with amyotrophic lateral sclerosis (ALS), who had polyvinylidene difluoride sheets. Unreactive binding sites not had any obvious infectious events during the 4 weeks were blocked with blocking solution containing 3% skim before the collection of the blood sample, were the controls. milk in phosphate-buffered saline. The blots were incubated for 2 h at room temperature with patients' sera diluted 1 : 200 in washing solution containing 0.2 M NaCl, 0.2% Triton X-
Laboratory investigations
100, and 0.05 M Tris-HCl, pH 7.5. The strips were washed,
Anti-H. influenzae antibody assay
then incubated for 2 h at room temperature with peroxidaseSerum anti-H. influenzae antibody titre was measured by the conjugated antibodies to human IgG diluted 1 : 1000 in enzyme-linked immunosorbent assay (ELISA), as described washing solution. After another wash, the reaction products previously (Kerttula et al., 1987; Yuki et al., 1992b; Burman were developed with enhanced chemiluminescence reagents et Kurtti et al., 1997) , but with the following minor (Amersham, San Francisco, Calif., USA) and exposed to film. modifications. Strains of non-typable H. influenzae isolated from the sputum of one of the patients with Guillain-Barré syndrome (Mori et al., 1999) enrolled in this study were Anti-ganglioside antibody assay used to prepare the H. influenzae antigen. They were grown IgG and IgM class antibodies to gangliosides GM2, GM1, on chocolate agar for 48 h at 37°C in 5% CO 2 , inactivated GM1b, GD1a, GalNac-GD1a, GD1b, GQ1b and GT1b were in 1% formaldehyde, then washed. The product was used as measured by an ELISA described elsewhere (Koga et al., the H. influenzae antigen. Wells of polystyrene plates were 1998b) by one person (M. Koga, School of Medicine, Dokkyo coated with the antigen in 100 µl carbonate buffer (50 mmol/l University). Antibody titre was the highest serum dilution at NaHCO 3 , 50 mmol/l Na 2 CO 3 , pH 9.6) then washed with which the optical density at 492 nm was ജ0.1. Serum was solution A (20 mmol/l Tris buffer, pH 7.4, 100 mmol/l NaCl, 0.5% skim milk, 0.05% Tween-20), after which they were considered positive when the titre was ജ1 : 500. 
Assays for anti-C. jejuni, anti-CMV and anti-M. pneumoniae antibodies
IgG anti-C. jejuni antibody also was measured by an ELISA described elsewhere . IgM antibodies against CMV were measured with the ELISA, IgM antibodies against EBV-specific capsid antigen with the indirect fluorescent antibody test, and M. pneumoniae antibodies with a commercial particle agglutination and complement fixation test (Special Reference Laboratory, Tokyo, Japan).
Electrodiagnostic studies
Nerve conduction studies were done by the conventional procedure within 3 weeks of onset of neurological signs. Patients were classified as having acute motor axonal neuropathy (AMAN) (motor axonal Guillain-Barré syndrome) or (demyelinating Guillain-Barré syndrome) using the electrothe sixth patient was not sampled sequentially after 2 weeks).
diagnostic criteria of Ho and colleagues (Ho et al., 1995) .
were classified as IgG in six cases, IgM in four, IgA in four,
Statistical analysis
both IgG and IgM in four, and both IgG and IgA in two. No Differences in proportions were tested with Fisher's exact patient had both IgM and IgA. All the antibodies in the test using StatView version 4.0 software. normal controls and in four patients with other neurological diseases were of the IgM class (one multiple sclerosis and three ALS patients). Positive serology for H. influenzae
Results
infection was significantly more frequent in patients with Guillain-Barré syndrome than in the normal controls (P ϭ
Anti-H. influenzae antibody assay
ELISA results of the IgG, IgM and IgA anti-H. influenzae 0.01) and patients with other neurological diseases (P ϭ 0.009). In patients with Guillain-Barré syndrome, IgG antiantibody assays are shown in Fig. 1 . Elevated anti-H. influenzae antibodies for two or three classes of IgG, H. influenzae antibody was positive more frequently than in normal controls (P ϭ 0.02) and patients with other IgM or IgA were present in six (13%) of the patients with Guillain-Barré syndrome, but not in the normal controls or neurological diseases (P ϭ 0.02). There were no significant differences in the frequencies of elevated IgM and IgA antipatients with other neurological diseases (multiple sclerosis or ALS). In the Guillain-Barré syndrome patients, antibodies H. influenzae antibodies among the three groups. Figure 2 patients had low compound muscle action potentials after distal stimulation (80% of normal lower limits) in multiple nerves, but no prolongation of distal latencies, decreases in conduction velocities, or temporal dispersion of responses. On electromyography 2 or 3 weeks after onset, there were ample fibrillation potentials in three of the four patients. In the other two patients who did not have the AMAN pattern, the absence of F waves was an isolated abnormality, and peripheral nerve conduction was entirely normal. Sensory nerve conduction was normal in all six patients. In all six patients, anti-ganglioside antibodies were present. Positivity for IgG anti-ganglioside antibodies was found for ganglioside GM1 (n ϭ 1), GM1b (n ϭ 1), GD1b (n ϭ 1) or GQ1b (n ϭ 1). Guillain-Barré syndrome patients were classified as having Western blot analysis showed that the sera from all of AIDP (n ϭ 18) or AMAN (n ϭ 21), or were unclassified six H. influenzae-positive Guillain-Barré syndrome patients (n ϭ 7). Of the 21 with AMAN, 19% (n ϭ 4) were recognized bands with a relative molecular mass of~10 kDa H. influenzae-positive. on LPS blots from H. influenzae (Fig. 3) and that the sera Of the 46 patients with Guillain-Barré syndrome, 35 had from all CMV-positive (n ϭ 3) and C. jejuni-positive (n ϭ IgG or IgM anti-ganglioside antibodies. IgG anti-ganglioside 3) Guillain-Barré syndrome patients did not recognize this antibodies were found for the gangliosides GM1 (n ϭ 20), band (Fig. 3) . None of the sera from the six H. influenzaeGM1b (n ϭ 17), GD1a (n ϭ 14), GalNac-GD1a (n ϭ 8), positive Guillain-Barré syndrome patients had antibody GD1b (n ϭ 12) and GQ1b (n ϭ 5), and IgM anti-ganglioside against the LPS from E. coli.
Relationship of H. influenzae-positive Guillain-
antibodies were found for GM1 (n ϭ 6), GM1b (n ϭ 3), GM2 (n ϭ 3), GD1b (n ϭ 1) and GQ1b (n ϭ 1). Anti-H. influenzae antibody was present in 17% of the
Clinical characteristics of H. influenzae-positive patients carrying IgG and/or IgM anti-ganglioside antibodies,

Guillain-Barré syndrome patients
25% of those with IgG anti-GM1 antibody, 42% of those The clinical, electrophysiological and serological features of with IgG anti-GD1b antibody and 29% of those with IgG these six patients are given in Tables 1 and 2. Respiratory anti-GD1a antibody. infections preceded the development of Guillain-Barré syndrome by 4-12 days in all the patients. Clinical features were characterized by less frequent cranial and sensory nerve involvement. Evolution was complete within 6 days. Clinical
Discussion
The aim of this retrospective study was to clarify the recovery was remarkably good, all six patients being able to walk unaided within 4 weeks and to run within 3 months.
association between H. influenzae infection and GuillainBarré syndrome using a case-control design, and to clarify the Sputum samples were obtained from five of the H. influenzae-positive patients, and Haemophilus species clinical and laboratory features of Guillain-Barré syndrome subsequent to H. influenzae infection. We found that a form were isolated from four of these specimens. Three were classified by species: two H. influenzae and one of Guillain-Barré syndrome occurs after respiratory infection by H. influenzae in the Japanese population. Guillain-Barré H. parainfluenzae. Both of the H. influenzae strains isolated from Guillain-Barré syndrome patients were serotyped as syndrome patients with H. influenzae infection were characterized clinically as having had a preceding respiratory non-typable (non-encapsulated).
Electrodiagnostic studies showed the AMAN pattern in tract infection, less frequent cranial and sensory nerve involvement, and good recovery. Moreover, they frequently four (67%) of the H. influenzae-positive patients. The four *0 ϭ healthy; 1 ϭ minor signs and symptoms; 2 ϭ able to walk 5 m independently; 3 ϭ able to walk 5 m with aid; 4 ϭ bedbound; 5 ϭ assisted respiration required; 6 ϭ dead. IVIg ϭ intravenous immunoglobulin therapy; PP ϭ plasmapheresis. (2000) GM1 (4000) GD1a (500) GM1 (8000) GM1 (500) GM1 (32 000) GM1b (1000) GD1b (500) GM1b (32 000) GD1a (500) GM1b (512 000) GD1a (2000) GD1b (1000) GD1b (2000) GD1a (128 000) GalNAc-GD1a
GQ1b (64 000) GD1b (8000) (4000) GD1b (4000) IgM GM1b (500) GM1 (1000) GD1b (500) GQ1b (4000) *Unclassified Haemophilus species.
had primary axonal involvement of the motor fibres and vaccine, which is composed of the capsular antigen of the bacteria (D'Cruz et al., 1989; Gervaix et al., 1993) , but carried anti-ganglioside antibodies. Most of these features agree with those of the Guillain-Barré syndrome associated subsequent evaluation has not confirmed this association (Gross and Hayes, 1991) . The non-typable (non-encapsulated) with C. jejuni enteritis (Rees et al., 1995a; Visser et al., 1995; Jacobs et al., 1996) . Our previous finding that a strain H. influenzae, however, has been shown to be an important pathogenetic cause of community-acquired bacterial of H. influenzae has a GM1-like structure and elicits GuillainBarré syndrome (Mori et al., 1999) is supported by the strong pneumonia in adults (Apicella, 1994), but had not been described as a pathogen of Guillain-Barré syndrome until association between the anti-H. influenzae positivity and the anti-GM1 positivity and the results of Western blotting our previous report (Mori et al., 1999) . Jacobs and colleagues reported that only 1% of 154 patients reported in this study.
Haemophilus influenzae is a Gram-negative human with Guillain-Barré syndrome had elevated anti-H. influenzae antibody and that there was no significant difference in the pathogen whose outer membrane contains LPS. There are two types of strain: encapsulated and non-encapsulated, nonpresence of the antibody when compared with the controls, including patients with other neurological diseases (Jacobs typable (Apicella, 1994) . The latter strain was used as the antigen in the ELISA carried out in this study. Previous et al., 1998) . There are a number of reasons for the different frequencies of Guillain-Barré syndrome patients with antireports suggest a causal relationship between Guillain-Barré syndrome and the H. influenzae type b (encapsulated type)
H. influenzae antibody in their study and ours. Jacobs and colleagues did not give a detailed description of the H. ganglioside-like structure (Mandrell et al., 1992; Gibson et al., 1993; Risberg et al., 1997) . Although GM1 was not influenzae used as antigen in the ELISA (they did not say whether the strain used was capsulated or was Guillainfound, the structure of the LPS was shown to differ among the strains. Elsewhere we have reported that a strain of Barré syndrome-related). Because the H. influenzae strain we isolated from Guillain-Barré syndrome patients was H. influenzae may have a GM1-like structure. In addition, almost all the anti-H. influenzae-positive patients in this study serotyped as non-typable and most pathogens that cause respiratory infections in adults are non-typable, we speculate had elevated IgG anti-GM1 antibodies. Moreover, Western blot analysis showed the presence of IgG antibodies against that only non-typable H. influenzae causes Guillain-Barré syndrome. The use of our isolated strain as the antigen may H. influenzae LPS in all the H. influenzae-positive patients, whereas these antibodies were not present in CMV-positive have yielded a higher percentage of H. influenzae-positive Guillain-Barré syndrome cases. In addition, a difference in or C. jejuni-positive Guillain-Barré syndrome patients. We speculate (i) that there is an H. influenzae strain that causes the populations of Guillain-Barré syndrome patients studied may have affected the frequency. Jacobs and colleagues Guillain-Barré syndrome, (ii) that this strain, like a certain C. jejuni strain, may carry a GM1-like epitope on its LPS, studied only patients with moderate to severe Guillain-Barré syndrome who were unable to walk 10 m independently, and (iii) that molecular mimicry between the ganglioside and the bacterial epitope may cause nerve damage because of an whereas we included all consecutive Guillain-Barré syndrome patients regardless of disease severity. In fact, one immune response. The similarities between Guillain-Barré syndrome subsequent to H. influenzae and C. jejuni infections of our H. influenzae-positive patients could walk unaided at the peak of illness. Finally, geographical differences may may reflect the same pathophysiology. Despite the high incidence of H. influenzae infection in the overall population, produce a difference in frequency. Different immunogenetic backgrounds, for example different human leukocyte antigen Guillain-Barré syndrome is a rare disease, probably because only a particular strain causes Guillain-Barré syndrome or haplotypes, may produce different susceptibilities to H. influenzae, as they do to the C. jejuni (Koga et al., 1998a) .
because persons who develop the disease differ in their responses to the infection. Japanese Guillain-Barré syndrome patients have been classified much more frequently as having the AMAN pattern
In our study, all the H. influenzae-positive Guillain-Barré syndrome patients could walk unaided within 4 weeks of the or being anti-GM1-positive (Kuwabara et al., 1998b) than patients in Western countries, where anti-GM1 antibody has nadir of the disease and could run within 3 months. Moreover, there seemed to be a better prognosis than that previously been found in 10-25% of patients with Guillain-Barré syndrome (Vriesendorp et al., 1993; Rees et al., 1995a;  described for C. jejuni-related Guillain-Barré syndrome patients (Rees et al., 1995a; Visser et al., 1995; Jacobs et al., Jacobs et al., 1996) and in only 7% of those with AMAN (Rees et al., 1995a (Rees et al., ). 1996 . Some reports have denied that there is a relationship between anti-GM1 antibody and C. jejuni infection or between False-positivity may occur in ELISA because H. influenzae is part of the normal flora of the upper respiratory tract and anti-GM1 antibody and a poor prognosis (Enders et al., 1993; Vriesendorp et al., 1993) . We found no significant correlation may occur together with other viral infections; moreover, there may be cross-reactions between H. influenzae and other between positivities for anti-GM1 and anti-H. influenzae antibodies. This may be because of the heterogeneity of the bacterial species (Murphy and Apicella, 1987; Loosmore et al., 1997) . Overestimation, however, is unlikely because anti-GM1 antibody-positive patient group, which consisted of at least two subgroups of patients with Guillain-Barré our ELISA method for the detection of anti-H. influenzae antibody is specific when used for the aetiological diagnosis syndrome subsequent to H. influenzae infection: those without anti-C. jejuni antibody who had a good recovery and those of pneumonia (Kerttula, 1987) ; H. influenzae was detected from purulent sputum specimens of two H. influenzae-positive with Guillain-Barré syndrome subsequent to C. jejuni infection who had a relatively poor recovery (Kuwabara Guillain-Barré syndrome patients; and there was no evidence of recent infection by any agent other than H. influenzae in et al., 1998a).
In conclusion, H. influenzae infection elicits an axonal form any of the sputum and serum specimens tested.
All the H. influenza-positive Guillain-Barré syndrome of Guillain-Barré syndrome associated with anti-ganglioside antibodies similar to those present in C. jejuni-related patients had antibodies of the IgG class, but did not always have IgM or IgA antibodies. Because Guillain-Barré Guillain-Barré syndrome, but there is better recovery from the H. influenzae-related form of the disease. syndrome develops 1-3 weeks after an infection, the titre of IgM or IgA antibody may decrease until the onset of neuropathic symptoms. In fact, the IgG anti-C. jejuni antibody assay is more sensitive than the IgM assay for C. jejuni-
